GHELARDONI, SANDRA Statistiche
GHELARDONI, SANDRA
DIPARTIMENTO DI PATOLOGIA CHIRURGICA, MEDICA, MOLECOLARE E DELL'AREA CRITICA
Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment
2026-01-01 Polini, Beatrice; Ghelardoni, Sandra; Capone, Gerarda; Monti, Emilia; Chiellini, Grazia; Lionetti, Vincenzo; De Caterina, Raffaele; Madonna, Rosalinda
Corrigendum “Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway” [Biomed. Pharmacother. 178 (2024), 117278]
2026-01-01 Mattii, Letizia; Moscato, Stefania; Ippolito, Chiara; Polizzi, Enza; Novo, Giuseppina; Zucchi, Riccardo; De Caterina, Raffaele; Ghelardoni, Sandra; Madonna, Rosalinda
Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis
2026-01-01 Biondi, Filippo; Ghelardoni, Sandra; Morrone, Doralisa; De Caterina, Raffaele; Madonna, Rosalinda
Galectin-3 binding protein is upregulated in heart failure with preserved ejection fraction and associated with endothelial nitric oxide synthase deficiency
2026-01-01 Madonna, Rosalinda; Cufaro, Maria Concetta; Gagliardi, Samuele; Morganti, Riccardo; Di Ferdinando, Fabio; Ghelardoni, Sandra; Marzoppi, Alessandra; Avagimyan, Ashot; Lionetti, Vincenzo; Ambrosio, Giuseppe; Fedele, Francesco; Del Boccio, Piero
Ambrisentan Retains Its Pro-Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes
2025-01-01 Cabiati, M.; Biondi, F.; Ghelardoni, S.; Casieri, V.; Lionetti, V.; Sgalippa, A.; Del Ry, S.; Madonna, R.
Sotatercept in pulmonary hypertension and beyond
2025-01-01 Madonna, R.; Ghelardoni, S.
Sotatercept: A Crosstalk Between Pathways and Activities in the Pulmonary Circulation and Blood
2025-01-01 Madonna, R.; Ghelardoni, S.
Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
2024-01-01 Madonna, R.; Biondi, F.; Alberti, M.; Ghelardoni, S.; Mattii, L.; D'Alleva, A.
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation
2024-01-01 Cristiani, S.; Bertolini, A.; Carnicelli, V.; Contu, L.; Vitelli, V.; Saba, A.; Saponaro, F.; Chiellini, G.; Sabbatini, A. R. M.; Giambelluca, M. A.; Lenzi, P.; Fornai, F.; Rossi, L.; Materazzi, G.; Ambrosini, C. E.; Rutigliano, G.; Zucchi, R.; Bizzarri, R.; Ghelardoni, S.
Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
2024-01-01 Mattii, L.; Moscato, S.; Ippolito, C.; Polizzi, E.; Novo, G.; Zucchi, R.; De Caterina, R.; Ghelardoni, S.; Madonna, R.
Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death
2024-01-01 Biondi, Filippo; Ghelardoni, Sandra; Moscato, Stefania; Mattii, Letizia; Barachini, Serena; Novo, Giuseppina; Zucchi, Riccardo; De Caterina, Raffaele; Madonna, Rosalinda
Pulmonary hypertension associated to left heart disease: Phenotypes and treatment
2024-01-01 Madonna, Rosalinda; Biondi, Filippo; Ghelardoni, Sandra; D'Alleva, Alberto; Quarta, Stefano; Massaro, Marika
Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis
2024-01-01 Madonna, R.; Barachini, S.; Ghelardoni, S.; Lu, L.; Shen, W. -F.; De Caterina, R.
Antineoplastic drugs inducing cardiac and vascular toxicity – An update
2023-01-01 Barachini, S.; Ghelardoni, S.; Varga, Z. V.; Mehanna, R. A.; Montt-Guevara, M. M.; Ferdinandy, P.; Madonna, R.
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy
2023-01-01 Madonna, Rosalinda; Moscato, Stefania; Cufaro, Maria Concetta; Pieragostino, Damiana; Mattii, Letizia; Del Boccio, Piero; Ghelardoni, Sandra; Zucchi, Riccardo; De Caterina, Raffaele
Farmaci antineoplastici e tossicità cardiovascolare
2023-01-01 Barachini, Serena; Ghelardoni, Sandra; Madonna, Rosalinda
La biochimica di Thomas M. Devlin
2023-01-01 Altieri, Fabio; Baldanzi, Gianluca; Borriello, Adriana; Cacciapuoti, Giovanna; Caraglia, Michele; Chiellini, Grazia; D’Andrea, Gabriele; Della Ragione, Fulvio; Di Domenico, Fabio; Di Liegro, Italia; Eufemi, Margherita; Ghelardoni, Sandra; Giovane, Alfonso; Lauricella, Marianna; Lupo, Gabriella; Mei, Giampiero; Giuseppe, Vincenzo; Noverina, Paola; Pignatti, Carla; Porcelli, Marina; Valli, Maurizia
Vascular Progenitor Cells: From Cancer to Tissue Repair
2023-01-01 Barachini, Serena; Ghelardoni, Sandra; Madonna, Rosalinda
Empaglifozin alleviates diabetic cariomyopathy via inhibiting excessive autophagy and adverse remodelling in type I diabetic mice.
2022-01-01 Madonna, R.; Moscato, S.; Cufaro, M.; Pieragostino, D.; Mattii, L.; Del Boccio, P.; Ghelardoni, S.; Zucchi, R.; De Caterina, R.
Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1)
2022-01-01 Bandini, Lavinia; Sacripanti, Ginevra; Borsò, Marco; Tartaria, Maria; Fogliaro, Maria Pia; Giannini, Giulia; Carnicelli, Vittoria; Figuccia, Matteo Emanuele; Verlotta, Sara; De Antoni, Fiammetta; Zucchi, Riccardo; Ghelardoni, Sandra
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment | 1-gen-2026 | Polini, Beatrice; Ghelardoni, Sandra; Capone, Gerarda; Monti, Emilia; Chiellini, Grazia; Lionetti, Vincenzo; De Caterina, Raffaele; Madonna, Rosalinda | |
| Corrigendum “Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway” [Biomed. Pharmacother. 178 (2024), 117278] | 1-gen-2026 | Mattii, Letizia; Moscato, Stefania; Ippolito, Chiara; Polizzi, Enza; Novo, Giuseppina; Zucchi, Riccardo; De Caterina, Raffaele; Ghelardoni, Sandra; Madonna, Rosalinda | |
| Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis | 1-gen-2026 | Biondi, Filippo; Ghelardoni, Sandra; Morrone, Doralisa; De Caterina, Raffaele; Madonna, Rosalinda | |
| Galectin-3 binding protein is upregulated in heart failure with preserved ejection fraction and associated with endothelial nitric oxide synthase deficiency | 1-gen-2026 | Madonna, Rosalinda; Cufaro, Maria Concetta; Gagliardi, Samuele; Morganti, Riccardo; Di Ferdinando, Fabio; Ghelardoni, Sandra; Marzoppi, Alessandra; Avagimyan, Ashot; Lionetti, Vincenzo; Ambrosio, Giuseppe; Fedele, Francesco; Del Boccio, Piero | |
| Ambrisentan Retains Its Pro-Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes | 1-gen-2025 | Cabiati, M.; Biondi, F.; Ghelardoni, S.; Casieri, V.; Lionetti, V.; Sgalippa, A.; Del Ry, S.; Madonna, R. | |
| Sotatercept in pulmonary hypertension and beyond | 1-gen-2025 | Madonna, R.; Ghelardoni, S. | |
| Sotatercept: A Crosstalk Between Pathways and Activities in the Pulmonary Circulation and Blood | 1-gen-2025 | Madonna, R.; Ghelardoni, S. | |
| Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review | 1-gen-2024 | Madonna, R.; Biondi, F.; Alberti, M.; Ghelardoni, S.; Mattii, L.; D'Alleva, A. | |
| Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation | 1-gen-2024 | Cristiani, S.; Bertolini, A.; Carnicelli, V.; Contu, L.; Vitelli, V.; Saba, A.; Saponaro, F.; Chiellini, G.; Sabbatini, A. R. M.; Giambelluca, M. A.; Lenzi, P.; Fornai, F.; Rossi, L.; Materazzi, G.; Ambrosini, C. E.; Rutigliano, G.; Zucchi, R.; Bizzarri, R.; Ghelardoni, S. | |
| Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway | 1-gen-2024 | Mattii, L.; Moscato, S.; Ippolito, C.; Polizzi, E.; Novo, G.; Zucchi, R.; De Caterina, R.; Ghelardoni, S.; Madonna, R. | |
| Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death | 1-gen-2024 | Biondi, Filippo; Ghelardoni, Sandra; Moscato, Stefania; Mattii, Letizia; Barachini, Serena; Novo, Giuseppina; Zucchi, Riccardo; De Caterina, Raffaele; Madonna, Rosalinda | |
| Pulmonary hypertension associated to left heart disease: Phenotypes and treatment | 1-gen-2024 | Madonna, Rosalinda; Biondi, Filippo; Ghelardoni, Sandra; D'Alleva, Alberto; Quarta, Stefano; Massaro, Marika | |
| Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis | 1-gen-2024 | Madonna, R.; Barachini, S.; Ghelardoni, S.; Lu, L.; Shen, W. -F.; De Caterina, R. | |
| Antineoplastic drugs inducing cardiac and vascular toxicity – An update | 1-gen-2023 | Barachini, S.; Ghelardoni, S.; Varga, Z. V.; Mehanna, R. A.; Montt-Guevara, M. M.; Ferdinandy, P.; Madonna, R. | |
| Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy | 1-gen-2023 | Madonna, Rosalinda; Moscato, Stefania; Cufaro, Maria Concetta; Pieragostino, Damiana; Mattii, Letizia; Del Boccio, Piero; Ghelardoni, Sandra; Zucchi, Riccardo; De Caterina, Raffaele | |
| Farmaci antineoplastici e tossicità cardiovascolare | 1-gen-2023 | Barachini, Serena; Ghelardoni, Sandra; Madonna, Rosalinda | |
| La biochimica di Thomas M. Devlin | 1-gen-2023 | Altieri, Fabio; Baldanzi, Gianluca; Borriello, Adriana; Cacciapuoti, Giovanna; Caraglia, Michele; Chiellini, Grazia; D’Andrea, Gabriele; Della Ragione, Fulvio; Di Domenico, Fabio; Di Liegro, Italia; Eufemi, Margherita; Ghelardoni, Sandra; Giovane, Alfonso; Lauricella, Marianna; Lupo, Gabriella; Mei, Giampiero; Giuseppe, Vincenzo; Noverina, Paola; Pignatti, Carla; Porcelli, Marina; Valli, Maurizia | |
| Vascular Progenitor Cells: From Cancer to Tissue Repair | 1-gen-2023 | Barachini, Serena; Ghelardoni, Sandra; Madonna, Rosalinda | |
| Empaglifozin alleviates diabetic cariomyopathy via inhibiting excessive autophagy and adverse remodelling in type I diabetic mice. | 1-gen-2022 | Madonna, R.; Moscato, S.; Cufaro, M.; Pieragostino, D.; Mattii, L.; Del Boccio, P.; Ghelardoni, S.; Zucchi, R.; De Caterina, R. | |
| Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1) | 1-gen-2022 | Bandini, Lavinia; Sacripanti, Ginevra; Borsò, Marco; Tartaria, Maria; Fogliaro, Maria Pia; Giannini, Giulia; Carnicelli, Vittoria; Figuccia, Matteo Emanuele; Verlotta, Sara; De Antoni, Fiammetta; Zucchi, Riccardo; Ghelardoni, Sandra |